or
forgot password
  • cancer clinical trials in connecticut

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Bendheim Cancer Center at Greenwich Hospital
    Greenwich, Connecticut 06830
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
    Yale University
    New Haven, Connecticut 06520
    Childhood Lymphocyte Predominant Hodgkin Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage II Childhood Hodgkin Lymphoma
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center

    Trial Locations
    Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Eastern Connecticut Hematology and Oncology Associates
    Melanoma (Skin)
    Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Colorectal Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Whittingham Cancer Center
    Prostate Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Hospital of St. Raphael
    New Haven, Connecticut 06511
    Head and Neck Cancer
    Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
    University of Connecticut Health Center

    Trial Locations
    University of Connecticut Health Center
    Yale Comprehensive Cancer Center
    Melanoma (Skin)
    Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors, Childhood Langerhans Cell Histiocytosis, Gastrointestinal Carcinoid Tumor, Head and Neck Cancer, Intraocular Melanoma, Islet Cell Tumor, Kidney Cancer, Lung Cancer, Melanoma (Skin), Neoplastic Syndrome, Neuroendocrine Carcinoma of the Skin, Pheochromocytoma
    High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Unspecified Adult Solid Tumor, Protocol Specific
    Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Unspecified Adult Solid Tumor, Protocol Specific
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Whittingham Cancer Center
    Head and Neck Cancer, Oral Complications
    Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Melanoma (Skin)
    Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Urology Specialists, P.C.
    Waterbury, Connecticut 06708
    Bladder Cancer
    MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Breast Cancer
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    University of Connecticut Health Center

    Trial Locations
    University of Connecticut Health Center
    Yale Comprehensive Cancer Center
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    University of Connecticut Health Center
    Farmington, Connecticut 06360-7106
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    St. Vincent's Medical Center

    Trial Locations
    St. Vincent's Medical Center
    Hospital of Saint Raphael
    Eastern Connecticut Hematology and Oncology Associates
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Sarcoma
    Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
    Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center

    Trial Locations
    Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Breast Cancer
    STI571 in Treating Patients With Recurrent Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Yale Comprehensive Cancer Center

    Trial Locations
    Yale Comprehensive Cancer Center
    Hospital of St. Raphael
    Prostate Cancer
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Ovarian Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Hospital of St. Raphael
    New Haven, Connecticut 06511
    Brain and Central Nervous System Tumors
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    University of Connecticut Health Center

    Trial Locations
    University of Connecticut Health Center
    Yale Comprehensive Cancer Center
    Leukemia
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Endometrial Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital

    Trial Locations
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hospital of Saint Raphael
    Eastern Connecticut Hematology and Oncology Associates
    Connecticut Oncology & Hematology - Torrington
    Lung Cancer
    Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
    Greenwich Hospital - Bendheim Cancer Center
    Greenwich, Connecticut 06830
    Breast Cancer
    Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
    New Britain General Hospital
    New Britain, Connecticut 06050
    Breast Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma